Tom Winnifrith Bearcast: Shield Therapeutics or Verditek - which sees a share price collapse first?
By Tom Winnifrith | Tuesday 21 June 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
I start with my wonderful son, Joshua, losing every race at Sports Day with bravery and humour. Then, onto UK Network Agency; Innovation Agri-Tech; Eden Pharma; the wretched FCA's failure on £65 million fraud, Appbox Media/One True View; Ocado (OCDO); Morses Club (MCL); Cake Box (CBOX) - where Steve is wrong; Verditek (VDTK); and Shield Therapeutics (STX).
You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism
Join us for free and gain access to three articles per month
Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.